E
Eve A. Olman
Researcher at University of Maryland, Baltimore
Publications - 4
Citations - 241
Eve A. Olman is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Renal function & Metabolite. The author has an hindex of 4, co-authored 4 publications receiving 241 citations. Previous affiliations of Eve A. Olman include University of Maryland Marlene and Stewart Greenebaum Cancer Center.
Papers
More filters
Journal Article
Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum.
TL;DR: In this article, the authors developed equations to calculate carboplatin dosage for any patient based on that patient9s creatinine clearance, body surface area, pretreatment platelet count, desired platelet nadir, and status of prior chemotherapy.
Journal ArticleDOI
The plasma pharmacokinetics and tissue distribution of dimethyl sulfoxide in mice.
Thomas S. Kaye,Thomas S. Kaye,Merrill J. Egorin,Merrill J. Egorin,Charles E. Riggs,Charles E. Riggs,Eve A. Olman,Eve A. Olman,Feng-te E. Chou,Feng-te E. Chou,Michael Salcman,Michael Salcman +11 more
TL;DR: Intravenous injection of DMSO produced little increase in plasma osmolality and did not produce any histological evidence of central nervous system or renal tubular damage, and was rapidly and extensively distributed through tissues and was not concentrated in any particular tissue.
Journal Article
The disposition of the new anthracycline antibiotic, menogarol, in mice
Pierre Dodion,Barbara K. Chang,Merrill J. Egorin,Eve A. Olman,Kathrin L. Engisch,Nicholas R. Bachur +5 more
TL;DR: Concentrations of 7-OMEN were the most persistent in spleen, kidney, and pancreas, and the least persistent in heart and liver, and in organs, a new anthracycline antibiotic entering clinical trials.